IP Library Granted Patent US 8,960,190
Granted Patent B2
US 8,960,190 · App. 12/594,388 · Granted Feb 24, 2015

Protective device

Inventors: John Paul James (Rugby, GB); James Prince Love (Coventry, GB); David John Maudsley (Kenilworth, GB)
Assignee: Medi-Immune Ltd.
A61L9/16A61L9/18A61L9/20A61L9/22A61M16/10A61M2016/0027A61M2016/0039A61M2202/203A61M2202/206A61M2205/053A62B18/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,960,190
App. No.
12/594,388
Granted
Feb 24, 2015
Kind
B2
Abstract

A protective device protects the user from infection and may simultaneously immunize the user against future infection. In an embodiment, the protective device includes a disinfection chamber wherein the chamber is arranged to disinfect and/or sterilize fluid in the chamber prior to discharge of the fluid from the chamber such that the fluid discharged from the chamber comprises inactive microorganisms. The device may include a disinfection chamber in fluid communication with a face mask, with the chamber arranged to disinfect and/or sterilize fluid in the chamber prior to discharge of the fluid from the chamber to the mask, such that the fluid discharged from the chamber to the mask comprises inactive microorganisms.

Claims (12)

1. A protective device for protection against infection from airborne microorganisms comprising a disinfection chamber in fluid communication with a face mask wherein the chamber is arranged to disinfect or sterilize fluid in the chamber by exposure to a UV source prior to discharge of the fluid from the chamber, wherein the UV source is selected from one of a fluorescent lamp or a light emitting diode, said UV source emitting UV radiation in the range of from 240 nm to 300 nm and an intensity of 75 W/m 2 to 350 W/m 2 , and wherein the dose of UV radiation delivered to the fluid by said UV source is in the range of 5-200 J/m 2 .

2. The protective device according to claim 1 , wherein the chamber is arranged to disinfect or sterilize fluid in the chamber prior to discharge of the fluid from the chamber to the mask.

3. The protective device according to claim 1 , wherein the fluid comprises a defective-interfering (DI) virus.

4. The protective device according to claim 1 , wherein the device is adapted for carrying by the user.

5. The protective device according to claim 1 , wherein the chamber is arranged to disinfect or sterilize fluid in the chamber prior to discharge of the fluid from the chamber to the external environment.

6. The protective device according to claim 1 , configured to provide a substantially constant disinfection or sterilization level.

7. The protective device according to claim 6 , wherein

the substantially constant disinfection or sterilization level is achieved by providing at least one of variable levels of shading to the UV source and variable levels of UV intensity, and

an increase in air-flow into the chamber is associated with at least one of a decrease in the level of shading of the UV source and an increase in the intensity of the UV source.

8. The device of claim 1 , wherein the dose of UV radiation is in the range of 30-90 J/m 2 .

9. The device according to claim 1 , wherein the fluid discharged from the chamber comprises inactive microorganisms comprising antigen.

10. The device according to claim 9 , wherein the antigen is capable of conferring immune protection on a recipient of the fluid.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE SPELLING OF THE ASSIGNEE CITY PREVIOUSLY RECORDED ON REEL 027058 FRAME 0244. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT SPELLING IS WARWICKSHIRE AS INDICATED ON THE ATTACHED ASSIGNMENT. Recorded Jan 21, 2015
From: JAMES, JOHN PAUL; LOVE, JAMES PRINCE; MAUDSLEY, DAVID JOHN
To: MEDI-IMMUNE LTD.
Reel/Frame 034793/0080 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECT EXECUTION DATE(S) OF THE ASSIGNMENT TO READ 6/24/2010, AS EXECUTED BY INVENTOR MAUDSLEY. PREVIOUSLY RECORDED ON REEL 026848 FRAME 0727. ASSIGNOR(S) HEREBY CONFIRMS THE THE ENTIRE RIGHT, TITLE AND INTEREST IN THE SUBJECT APPLICATION, EXECUTED ON 8/12/2010; 7/20/2010 AND 6/24/2010 RESPECTIVELY.. Recorded Sep 29, 2011
From: JAMES, JOHN PAUL; LOVE, JAMES PRINCE; MAUDSLEY, DAVID JOHN
To: MEDI-IMMUNE LTD.
Reel/Frame 027058/0244 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2011
From: JAMES, JOHN PAUL; LOVE, JAMES PRINCE; MAUDSLEY, DAVID JOHN
To: MEDI-IMMUNE LTD.
Reel/Frame 026848/0727 →
Priority Claims (1)
GB 0706507.1 · Apr 3, 2007 · national
Continuity (1)
Related Publication 20100175694A1 · Jul 15, 2010